Phase 3,randomized,double-blind,clinical trial of IKH-01 for treatment of dysmenorrhea associated with endometriosis.
Phase 3
- Conditions
- dysmenorrhea associated with endometriosis.
- Registration Number
- JPRN-jRCT2080220111
- Lead Sponsor
- obelpharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Age limit:minimum 18years
dysmenorrhea associated with endometriosis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method